VA Pharmacists Detail Buprenorphine Protocol for Acute 7-OH Withdrawal in New Case Report

Why it matters

As concentrated 7-OH products proliferate, clinicians need evidence-based protocols for managing withdrawal -- this case report from Jesse Brown VA Medical Center provides a concrete pharmacist-focused treatment roadmap.

The big picture

Concentrated 7-OH products are increasingly reaching emergency departments and addiction clinics, where clinicians are finding that withdrawal resembles opioid withdrawal but requires careful management to avoid buprenorphine-precipitated withdrawal. This case report is among the first to formally document management of 7-OH withdrawal with buprenorphine and adjunct medications.

Key findings

• A 43-year-old male with opioid use disorder presented with acute withdrawal after stopping 360 mg per day of concentrated 7-OH
• He had transitioned from natural kratom to 7-OH 18 months earlier, seeking stronger and faster opioid-like effects
• Clinical opioid withdrawal scale score was 5; he met DSM-V criteria for moderate opiate use disorder
• He was treated with sublingual buprenorphine-naloxone 4-1 mg plus clonidine, ondansetron, loperamide, muscle relaxants, and NSAIDs
• A Naranjo causality assessment score of 6 confirmed probable causality between 7-OH use and withdrawal symptoms
• Authors recommend pharmacists screen patients for 7-OH use and carefully time buprenorphine initiation to avoid precipitated withdrawal

What they say

"Concentrated 7-OH products differ from kratom leaf and can produce dependence and withdrawal; pharmacists should screen for these products, time buprenorphine initiation to moderate withdrawal, provide harm-reduction counseling, and incorporate evolving state regulations into patient education." -- Lybik et al., Journal of the American Pharmacists Association

Bottom line

This VA case report establishes a practical protocol for managing 7-OH withdrawal using buprenorphine, reinforcing the clinical distinction between natural kratom leaf and highly concentrated synthetic 7-OH products.